GSK Scientists Knew About Zantac's Cancer Risks For Forty Years
By Herman James / February 20, 2023 / marketsanity.com / Article Link
Zero Hedge, Released on 2/20/23
Three years after the Food & Drug Administration (FDA) pulled GSK Plc's heartburn drug Zantac off the market due to suspected links to cancer, and just two weeks before the trial
GSK Scientists Knew About Zantac's Cancer Risks For Forty Years added by Herman James on 02/20/2023View all posts by Herman James ?+'
Recent News
Energy outperforms gold and tech for first time in years
March 23, 2026 / www.canadianminingreport.com
Gold stocks crash along with metal price
March 23, 2026 / www.canadianminingreport.com
Mining stock ETFs slide, gold sector valuations high
March 16, 2026 / www.canadianminingreport.com
Rise in oil price a potential net gain for Canada
March 16, 2026 / www.canadianminingreport.com
Gold stocks slump partly on fears of cost increases
March 09, 2026 / www.canadianminingreport.com